Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Patients With Resectable Gastroesophageal Junction and Gastric Cancer
- PMID: 29136992
- DOI: 10.1097/SLA.0000000000001596
Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Patients With Resectable Gastroesophageal Junction and Gastric Cancer
Comment in
-
Reply to "Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Patients With Resectable Gastroesophageal Junction and Gastric Cancer".Ann Surg. 2017 Dec;266(6):e77. doi: 10.1097/SLA.0000000000001641. Ann Surg. 2017. PMID: 29136993 No abstract available.
Comment on
-
Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma.Ann Surg. 2016 Feb;263(2):292-7. doi: 10.1097/SLA.0000000000001189. Ann Surg. 2016. PMID: 25915915 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
